171
Views
9
CrossRef citations to date
0
Altmetric
Research Articles

Patterns of attendance in methadone maintenance treatment program in Yunnan Province, China

, M.D., , M.D., Ph.D., , MSc., , M.D., , M.D., Ph.D. & , M.D., Ph.D.
Pages 148-154 | Published online: 18 Mar 2011

References

  • UNODC. World drug report. Geneva: United Nations Office on Drugs and Crime, 2008.
  • Fan C, Hao W, Yang D. The third national epidemiological survey on illicit drug use at six high prevalence areas in China. Chin J Drug Depend 2004; 13(1):55–59.
  • Center NDUS. Annual report on drug surveillance 2001. Beijing: NDSAC in National Institute on Drug Dependence PR China, 2001.
  • HAARP Yunnan Office. Yunnan HAARP Progress Report (draft), 2008.
  • Bertschy G. Methadone maintenance treatment: an update. Eur Arch Psychiatry Clin Neurosci 1995; 245(2):114–124.
  • Farré M, Mas A, Torrens M, Moreno V, Camí J. Retention rate and illicit opioid use during methadone maintenance interventions: aA meta-analysis. Drug Alcohol Depend 2002; 65(3):283–290.
  • Sorensen J, Copeland A. Drug abuse treatment as an HIV prevention strategy: a review. Drug Alcohol Depend 2000; 59(1):17–31.
  • Marsch LA. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction 1998; 93(4):515–532.
  • Langendam M, van Brussel G, Coutinho R, van Ameijden EJ. The impact of harm-reduction-based methadone treatment on mortality among heroin users. Am J Public Health; 2001; 91(5):774–780.
  • Weber R, Ledergerber B, Opravil M, Siegenthaler W, Lüthy R. Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone. BMJ 1990; 301(6765):1362–1365.
  • Padaiga Z, Subata E, Vanagas G. Outpatient methadone maintenance treatment program. Quality of life and health of opioid-dependent persons in Lithuania.; Medicina (Kaunas) 2007; 43(3):235–241.
  • Maremmani I, Pani P, Pacini M, Perugi G. Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients.; J Subst Abuse Treat 2007; 33(1):91–98.
  • Henry-Edwards S, Gowing L, White J, Ali R, Bell J, Brough R, Lintzeris N, Ritter A, Quigley A. Clinical guidelines and procedures for the use of methadone in the maintenance treatment of opioid dependence. National Drug Strategy Canberra, Australian Government, 2003.
  • Ward J, Mattick R, Hall We. Methadone Maintenance Treatment and Other Opioid Replacement Therapies. Amsterdam, The Netherlands: Harwood Academic Publishers, 1997; 471.
  • A joint assessment of HIV/AIDS prevention, treatment and care in China Beijing, P.R. China: State Council AIDS Working Committee Office UN Theme Group on AIDS in China, December 1, 2007.
  • CSIS HIV/AIDS Task Force. Defusing China's time bomb: Sustaining the momentum of China's HIV/AIDS response. Washington, DC: Center for Strategic and International Studies, 2004.
  • R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria; ISBN 3-900051-07-0; Available at The website should be www.R-project.org. Accessed on November 15, 2010.
  • Chongsuvivatwong V. Analysis of epidemiological data using R and Epicalc. Hat Yai, Songkhla, Thailand: Prince of Songkla University 2008.
  • Michels II. AIDS as a challenge for the development of the treatment of opioid dependents in China. The 9th National Conference on Drug Dependence, MMT and HIV prevention in Sanya/Hainan, China, 2006.
  • Amato L, Minozzi S, Davoli M, Vecchi S, Ferri MM, Mayet S. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence (Review). Cochrane Database Syst Rev 2008:(4): CD004147.
  • Ward J, Hall W, Mattick RP. Role of maintenance treatment in opioid dependence. Lancet 1999; 353:221–226.
  • Magura S, Nwakeze PC, Demsky S. Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction 1998; 93(1):51–60.
  • Esteban J, Gimeno C, Barril J, Aragonés A, Climent JM, de la Cruz Pellín M.Survival study of opioid addicts in relation to its adherence to methadone maintenance treatment. Drug Alcohol Depend 2003; 70:193–200.
  • Peles E, Schreiber S, Adelson M. Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel. Drug Alcohol Depend 2006 May; 82(3):211–217.
  • Torrens M, Castillo C, Perez-Sola V. Retention in a low-threshold methadone maintenance program. Drug Alcohol Depend 1996; 41(1):55–59.
  • Yang F, Lin P, Wang Y. Qualitative study on drug use and syringe sharing among IDUs in Guangdong. Guangdong J Health Epid Prev 2004; 30(6):1–4.
  • Zhou Z, Tan A, Huang L. Investigation on high risk behaviors among male drug users with needle sharing. South China J Prev Med 2007; 33(1).
  • Dickinson GL, Rostami-Hodjegan A, Lagundoye O, Seivewright N, Pratt P, Lennard MS. A six-year evaluation of methadone prescribing practices at a substance misuse treatment centre in the UK.; J Clin Pharm Ther; 2006; 31(5):477–484.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.